Back

Targeting lipoprotein(a)

31 August 2026 (08:33 - 08:51)
Organised by: Logo
Congress Presentation Part of: Assessing and treating 'residual risk' beyond low-density lipoproteins Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Borge Nordestgaard

Copenhagen University Hospital, Copenhagen (Denmark)

4 More presentations in this session

Presentation thumbnail
Optimal ways to identify high-risk cohorts beyond low-density lipoproteins: unmet high-risk patients
Doctor P. Ridker (Boston, US)
Slides Video
Presentation thumbnail
Colchicine: who benefits?
Doctor J. Tardif (Montreal, CA)
Slides Video
Presentation thumbnail
GLP1 agonist: for everyone?
Professor E. Michos (Baltimore, US)
Slides Video
Presentation thumbnail
Assessing and treating 'residual risk' beyond low-density lipoproteins - discussion
Video

Access the full session

Session thumbnail
Assessing and treating 'residual risk' beyond low-density lipoproteins
Video

The Event

Event poster

ESC Congress 2026

31 August 2026 08:33 CET
You may be interested in
thumbnail
Congress Session
Lp(a) and cardiovascular disease: unveiling the hidden threat
29 August 2025
thumbnail
Congress Presentation
How to assess risk in the patient with high lipoprotein(a)
30 August 2026
thumbnail
Congress Presentation
Why measure lipoprotein(a)?
30 August 2026
thumbnail
Congress Presentation
Lp(a), aortic valve stenosis, and atherosclerosis
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources